Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Multiple Myeloma × Immunoconjugates × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Recurrence 1 Multiple Myeloma 1 Breast Neoplasms 1

Interventions

Dexamethasone 111 Lenalidomide 60 Bortezomib 59 Cyclophosphamide 58 Calcium Dobesilate 42 fludarabine 36 pomalidomide 34 daratumumab 34 carfilzomib 29 fludarabine phosphate 22 Melphalan 22 dexamethasone 21-phosphate 18 dexamethasone acetate 17 auricularum 16 Filgrastim 16 Whole-Body Irradiation 14 Biopsy 13 Magnetic Resonance Spectroscopy 12 isatuximab 11 Vorinostat 11 Specimen Handling 11 Peripheral Blood Stem Cell Transplantation 10 Granulocyte Colony-Stimulating Factor 10 venetoclax 9 ixazomib 9 belantamab mafodotin 9 Tacrolimus 9 Cyclosporine 9 Sirolimus 8 Rituximab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03489525 2022-03-28

MEDI2228

MedImmune LLC

Phase 1 Completed

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡